$1.02
0.0199[1.99%]
At close: Apr 25
$1.02
0[0.00%]
After Hours: 9:28AM EDT
Sensei Biotherapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Sensei Biotherapeutics using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|---|
05/07/2024 | AM | SNSE | Q1 | -$0.33 | -$0.27 | — | — | $0.00 | — | — | — | Get Alert |
02/28/2024 | AM | SNSE | Q4 | -$0.40 | -$0.31 | -$0.30 | 3.23% | $0.00 | — | $0.00 | — | Get Alert |
11/07/2023 | AM | SNSE | Q3 | -$0.44 | -$0.34 | -$0.28 | 17.65% | $0.00 | — | $0.00 | — | Get Alert |
08/03/2023 | AM | SNSE | Q2 | -$0.34 | -$0.33 | -$0.31 | 6.06% | $0.00 | — | $0.00 | — | Get Alert |
05/09/2023 | AM | SNSE | Q1 | -$0.40 | -$0.36 | -$0.33 | 8.33% | $0.00 | — | $0.00 | — | Get Alert |
03/28/2023 | AM | SNSE | Q4 | -$0.30 | -$0.40 | -$0.40 | 0.00% | $0.00 | — | $0.00 | — | Get Alert |
11/08/2022 | AM | SNSE | Q3 | -$0.32 | -$0.37 | -$0.44 | -18.92% | $0.00 | — | $0.00 | — | Get Alert |
08/09/2022 | AM | SNSE | Q2 | -$0.32 | -$0.41 | -$0.34 | 17.07% | $0.00 | — | $0.00 | — | Get Alert |
05/10/2022 | AM | SNSE | Q1 | -$0.42 | -$0.35 | -$0.40 | -14.29% | $0.00 | — | $0.00 | — | Get Alert |
03/10/2022 | AM | SNSE | Q4 | — | -$0.34 | -$0.30 | 11.76% | — | — | $0.00 | — | Get Alert |
11/09/2021 | AM | SNSE | Q3 | -$3.00 | -$0.24 | -$0.32 | -33.33% | — | — | $0.00 | — | Get Alert |
08/04/2021 | AM | SNSE | Q2 | -$3.02 | -$0.29 | -$0.32 | -10.34% | — | — | $0.00 | — | Get Alert |
05/12/2021 | AM | SNSE | Q1 | -$4.00 | -$0.30 | -$0.42 | -40.00% | — | — | $0.00 | — | Get Alert |
Sensei Biotherapeutics (SNSE) is scheduled to report earnings on May 7, 2024. The last reported earnings were for reported on February 28, 2024 for Q4.
The Actual EPS was $-0.30, which beat the estimate of $-0.31.
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.